KA Imaging
KA Imaging is a Canadian medical imaging company that designs and manufactures X-ray detectors and systems powered by its proprietary SpectralDR single-exposure multi-energy technology, serving hospitals, industrial NDT labs, research institutions, veterinary clinics, and defense/security customers globally.
- Company typePrivate
- Founded2015
- HeadquartersWaterloo, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What KA Imaging does
KA Imaging is a Canadian designer and manufacturer of X-ray detectors and imaging systems, founded in 2015 as a spin-off from the University of Waterloo and headquartered in Waterloo, Ontario. The company serves medical hospitals, industrial NDT customers, scientific research institutions, veterinary clinics, and defense/security organizations across Canada, the United States, Hong Kong, Australia, Nigeria, and Kenya. Its installed base includes University Health Network in Toronto, Grand River Hospital in Kitchener, Canossa Hospital in Hong Kong, and TB screening programs in Nigeria and Kenya.
The company's core technology is SpectralDR, a patented single-exposure multi-energy X-ray platform built on a triple-layer detector design that captures three co-registered images (standard DR, soft tissue, and bone) in one exposure without motion artifacts or increased radiation dose. This technology underpins the Reveal 35C medical detector, the IP55-rated Reveal R 35C ruggedized NDT detector, the Reveal Mobi Pro and Mobi Lite mobile systems (developed with Del Medical), and the inCiTe and inCiTe 2.0 micro-CT platforms, the last of which also uses the BrillianSe direct-conversion a-Se/CMOS detector for phase contrast imaging at 60 lp/mm.
KA Imaging generates revenue primarily through hardware sales via direct enterprise field sales to hospitals and through channel partners and distributors internationally, with quote-based pricing and multi-year contracts. Revenue grew 44% in 2024 alongside 16% staff expansion, supported by three major product launches that year. The company has secured FDA 510(k), Health Canada, CE Mark under EU MDR, and ASTM F792-17 clearances, and in 2025-2026 it expanded into Asia-Pacific (Hong Kong, Australia), entered EV battery quality assurance via a partnership with Dana Canada, and was selected for the INOVAIT Pilot Fund to develop AI-based triage software for spectral X-ray imaging.
KA Imaging firmographics
Firmographics- Name
- KA Imaging
- Legal name
- KA Imaging Inc.
- Website
- https://kaimaging.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- KA Imaging is a Canadian medical imaging company that designs and manufactures X-ray detectors and systems powered by its proprietary SpectralDR single-exposure multi-energy technology, serving hospitals, industrial NDT labs, research institutions, veterinary clinics, and defense/security customers globally.
- Ownership category
- akta.pro rank
KA Imaging industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Irradiation Apparatus Manufacturing (334517), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- X-ray & Fluoroscopy Systems (HLAHABAA)
- akta.pro secondary industries
- Inspection, Checkweighing & Detection Systems (Vision, Metal, X-ray) (IMALAOAH), CT/X-ray & Non-Destructive Testing (NDT) for AM Parts (IMAAAHAG)
Keywords
Where KA Imaging is headquartered
LocationHeadquarters
- HQ city
- Waterloo
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
KA Imaging business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical X-ray Detector and System Sales: KA Imaging generates revenue primarily through the sale of medical X-ray detectors (Reveal 35C) and mobile X-ray systems (Reveal Mobi Pro, Reveal Mobi Lite). Revenue grew 44% in 2024 compared to the previous year. The company operates in both direct sales and through distribution partners.
- NDT / Industrial X-ray Detector and System Sales: KA Imaging sells non-destructive testing products including Reveal R 35C ruggedized detector, inCiTe and inCiTe 2.0 micro-CT systems, and BrillianSe detectors to industrial, aerospace, electronics, and research customers. Target markets include quality control, failure analysis, and materials science.
- Veterinary X-ray Imaging Solutions: SpectralDR-powered solutions are sold for equine and small animal imaging in veterinary markets, addressing diagnostic imaging needs in veterinary clinics.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | No public pricing available |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
KA Imaging product offering
Product offeringCore offering
KA Imaging designs and manufactures proprietary X-ray detectors and integrated imaging systems powered by its patented SpectralDR single-exposure multi-energy technology. The company sells flat-panel detectors (Reveal 35C, Reveal R 35C, BrillianSe, Sight), mobile X-ray systems (Reveal Mobi Pro, Reveal Mobi Lite), and micro-CT platforms (inCiTe, inCiTe 2.0) for medical, veterinary, industrial non-destructive testing, defense/security, and scientific research customers.
Product overview
KA Imaging offers a platform-plus-products architecture built around its proprietary SpectralDR technology. The core portfolio includes X-ray detectors (Reveal 35C for medical, Reveal R 35C for ruggedized NDT applications, BrillianSe for high-resolution micro-CT, and Sight for lightweight applications), mobile X-ray systems (Reveal Mobi Pro and Reveal Mobi Lite integrating the SpectralDR-powered detectors), and 3D X-ray microscopes (inCiTe and inCiTe 2.0). The SpectralDR technology serves as the foundational platform enabling all Reveal products to capture multiple images from a single exposure. Accessories include portable packages (Sedecal, Remedi) and non-medical NDT packages. The company also develops phase contrast micro-CT solutions using BrillianSe detector technology.
Differentiator
Problem solved
Functional benefit
Brands
- SpectralDR: Proprietary single-exposure multi-energy X-ray technology that enables dual-energy imaging capabilities in portable applications
- Reveal
- BrillianSe
- inCiTe
- Reveal Mobi Pro
- Reveal Mobi Lite
- Sight
Products and services
- Reveal 35C Dual-energy flat panel X-ray detector with SpectralDR technology that captures three images (standard DR, soft tissue, and bone) from a single X-ray exposure without increasing dose or requiring workflow changes. Designed for medical imaging applications including pneumonia detection, lung lesion visibility, line/tube placement confirmation, and ICU/critical care bedside imaging.
- Reveal R 35C Ruggedized triple-energy X-ray detector with SpectralDR technology designed for non-destructive testing in harsh industrial and field environments. Features IP55 rating, reinforced enclosure, tripod quick mount, and ASTM F792-17 compliance for airport security applications.
- Reveal Mobi Pro Premium mobile dual-energy X-ray system integrating the Reveal 35C detector with SpectralDR technology into a mobile platform for bedside imaging in ICU and critical care. Developed in collaboration with Del Medical, Inc.
- Reveal Mobi Lite Mobile X-ray system featuring SpectralDR technology for portable bedside imaging applications.
- BrillianSe High-resolution X-ray detector using direct conversion amorphous Selenium (a-Se) on CMOS technology. Features 8-micron pixel size achieving 60 lp/mm spatial resolution and high DQE at low radiation levels, designed for phase contrast micro-CT applications.
- inCiTe 3D X-ray microscope utilizing BrillianSe detector for high-resolution phase contrast imaging. Designed for low-density material imaging in life sciences, electronics, agricultural, and pharmaceutical applications with submicron voxel resolution.
- inCiTe 2.0 Configurable micro-CT system integrating both phase contrast and spectral imaging capabilities. Combines BrillianSe and Reveal detectors for multi-contrast material analysis, designed as an alternative to traditional Scanning Electron Microscopy (SEM).
- Sight Lightweight flat panel X-ray detector for medical imaging solutions.
Quantifiable outcome
- 33% more pneumonia cases found compared to standard X-ray with Reveal 35C dual-energy images
- +7 more outcomes
Companies that use KA Imaging
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
KA Imaging technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature7 records
KA Imaging partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered key, core and supporting.
- University of Waterloo (Dr. Elliot Creager)keyKA Imaging was selected for the INOVAIT Pilot Fund to develop an AI-based triage tool for pulmonary health using data from the Reveal 35C detector with SpectralDR technology. Dr. Elliot Creager at the University of Waterloo is collaborating on the project. The resulting software will integrate with KA Imaging's mobile spectral X-ray systems to automatically analyze bedside spectral X-rays and prioritize cases for clinician review, with a demonstration expected in 2027.
- ScinticacoreKA Imaging partnered with Scintica to bring its 3D X-ray imaging platform (inCiTe) to more preclinical and biomedical research groups across North America. Scintica distributes the inCiTe platform supporting work in materials and life sciences research areas.
- OBIO (Ontario Bioscience Innovation Organization)supportingUniversity Health Network in Toronto adopted Reveal Mobi Pro with support from OBIO's programs and government agencies. OBIO supports Ontario-based life science companies in accessing capital, talent, and corporate partners, facilitating the adoption of innovative health technologies in the province.
- Dana Canada Corporation (Subsidiary of Dana Incorporated)coreKA Imaging is collaborating with Dana Canada Corporation to develop an inline X-ray phase contrast system for real-time micro-defect detection in EV battery component manufacturing. This is part of a nearly $3 million project backed by $1 million from Ontario through OVIN R&D Partnership Fund. The system aims to proactively catch micro-defects at faster production speeds, reducing scrap rates, improving safety, and driving down EV costs.
- Ontario Vehicle Innovation Network (OVIN)coreOVIN, an initiative of the Government of Ontario led by the Ontario Centre of Innovation (OCI), provided $1 million through the OVIN R&D Partnership Fund to support KA Imaging's EV battery quality assurance imaging project in partnership with Dana Canada. OVIN is part of Ontario's strategy to reinforce its position as a leader in advanced automotive technology and electric vehicles.
- Grand Challenges CanadasupportingGrand Challenges Canada is listed as a partner on KA Imaging's website. Grand Challenges Canada supports bold ideas with big impact in global health, which aligns with KA Imaging's work in global health imaging and TB detection in Nigeria and Kenya.
- Ontario Centre of Innovation (OCI)supportingOCI (Ontario Centre of Innovation) is listed as a partner on KA Imaging's website and is leading the OVIN initiative. OCI is Ontario's agency for advancing cutting-edge technologies and commercialization, working with government, academia, and industry.
Scale indicators7 records
Recent moves6 records
Expansion highlights7 records
KA Imaging competitors and assessment
Company assessmentDirect peers
- MARS Bioimaging: MARS Bioimaging develops spectral/colour X-ray imaging using Medipix3-based photon-counting detectors, the most direct technology competitor to KA Imaging's SpectralDR triple-energy approach. Both companies pursue single-exposure material decomposition for medical imaging and represent the leading edge of spectral X-ray commercialization.
- Varex Imaging: Varex Imaging is a leading independent supplier of X-ray imaging components, including flat panel detectors and X-ray tubes, serving medical and industrial OEMs. As a component-level peer, Varex competes with KA Imaging's Reveal detector line at the OEM integration layer across medical and industrial X-ray markets.
- Konica Minolta Healthcare Americas: Konica Minolta Healthcare manufactures digital radiography (DR) systems and AeroDR wireless detectors used in hospitals, imaging centers, and clinics. It directly competes with KA Imaging's portable Reveal detectors in the bedside, mobile, and fixed X-ray segments.
- Agfa-Gevaert (Agfa HealthCare): Agfa HealthCare produces direct radiography (DR) systems, computed radiography (CR), and enterprise imaging solutions for hospitals. Its DR detector and mobile X-ray portfolio competes directly with KA Imaging's Reveal 35C and Reveal Mobi product lines in hospital procurement.
- Vieworks: Vieworks is a Korean manufacturer of digital X-ray detectors and imaging systems for medical, dental, veterinary, and industrial applications. Its flat panel detector portfolio directly competes with KA Imaging's Reveal 35C and Reveal R 35C in OEM and end-user channels.
- YXLON International (Comet Group): YXLON International manufactures industrial X-ray inspection systems and CT solutions for non-destructive testing in aerospace, automotive, and electronics. It competes with KA Imaging's inCiTe micro-CT and Reveal R 35C ruggedized detector in industrial NDT applications.
- Bruker micro-CT: Bruker offers micro-CT systems (SkyScan) for preclinical research, materials science, and quality control. Its benchtop and high-resolution micro-CT platforms directly compete with KA Imaging's inCiTe and inCiTe 2.0 in scientific and biomedical research markets.
Broad incumbents
- Carestream Health: Carestream Health is a broad incumbent in medical imaging, offering DR/CR systems, mobile X-ray, and enterprise imaging software. It competes with KA Imaging across hospital radiology departments with bundled solutions and established service networks.
- Fujifilm Healthcare: Fujifilm Healthcare offers a comprehensive portfolio of X-ray, mammography, endoscopy, and enterprise imaging solutions. As a broad incumbent, its DR and mobile X-ray systems compete with KA Imaging's portable dual-energy offerings in hospital channels.
- Teledyne Technologies (Digital Imaging): Teledyne's digital imaging businesses (including Teledyne DALSA and Teledyne ICM) supply CCD/CMOS sensors and X-ray detector components used in medical, scientific, and industrial imaging. It represents a broad incumbent in detector and sensor technology adjacent to KA Imaging's detector manufacturing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
KA Imaging social profiles
Digital presenceKA Imaging compliance and trust
Trust signalCompliance4 records
KA Imaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
KA Imaging leadership team
Management profileNumber of profiles
Profiles5 records
KA Imaging funding detail
Funding detailFunding overview
Funding rounds8 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KA Imaging M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KA Imaging
What does KA Imaging do?
KA Imaging designs and manufactures proprietary X-ray detectors and integrated imaging systems powered by its patented SpectralDR single-exposure multi-energy technology. The company sells flat-panel detectors (Reveal 35C, Reveal R 35C, BrillianSe, Sight), mobile X-ray systems (Reveal Mobi Pro, Reveal Mobi Lite), and micro-CT platforms (inCiTe, inCiTe 2.0) for medical, veterinary, industrial non-destructive testing, defense/security, and scientific research customers.
Is KA Imaging a public or private company?
KA Imaging is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was KA Imaging founded?
KA Imaging was founded in 2015. It employs 11 to 50 people.
Where is KA Imaging based?
KA Imaging is headquartered in Waterloo, Canada, in the North America region.
How does KA Imaging make money?
Three revenue lines are on record. Medical X-ray Detector and System Sales are the primary driver. The others are NDT / Industrial X-ray Detector and System Sales and veterinary X-ray Imaging Solutions.
Who are KA Imaging's main competitors?
Direct peers on record are MARS Bioimaging, Varex Imaging, Konica Minolta Healthcare Americas, Agfa-Gevaert (Agfa HealthCare), Vieworks, YXLON International (Comet Group) and Bruker micro-CT. Broad incumbents are Carestream Health, Fujifilm Healthcare and Teledyne Technologies (Digital Imaging).
Does KA Imaging have an API?
No public API is recorded for KA Imaging.
What industry is KA Imaging in?
KA Imaging's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAA, X-ray & Fluoroscopy Systems, with a secondary code of IMALAOAH, Inspection, Checkweighing & Detection Systems (Vision, Metal, X-ray). Its NAICS code is 334517 and its SIC code is 3844.